Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BGIN
Bgin Blockchain
$1.70
-4.1%
$2.00
$1.61
$6.50
$200.56MN/A8,470 shs1,481 shs
Expensify, Inc. stock logo
EXFY
Expensify
$2.22
-3.9%
$1.71
$0.69
$2.81
$182.34M1.671.10 million shs1.03 million shs
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
$4.15
-1.2%
$4.41
$2.73
$5.75
$49.88M0.9312,579 shs17,359 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$3.89
+0.5%
$8.56
$3.77
$21.41
$199.04M-0.2488,035 shs236,035 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BGIN
Bgin Blockchain
-2.58%-4.06%-10.15%-52.65%+169,999,900.00%
Expensify, Inc. stock logo
EXFY
Expensify
-3.90%+9.90%+24.02%+94.74%+23.33%
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
-1.19%-3.04%-4.60%0.00%+2.72%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
+0.52%-5.35%-45.97%-60.47%-65.21%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BGIN
Bgin Blockchain
$1.70
-4.1%
$2.00
$1.61
$6.50
$200.56MN/A8,470 shs1,481 shs
Expensify, Inc. stock logo
EXFY
Expensify
$2.22
-3.9%
$1.71
$0.69
$2.81
$182.34M1.671.10 million shs1.03 million shs
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
$4.15
-1.2%
$4.41
$2.73
$5.75
$49.88M0.9312,579 shs17,359 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$3.89
+0.5%
$8.56
$3.77
$21.41
$199.04M-0.2488,035 shs236,035 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BGIN
Bgin Blockchain
-2.58%-4.06%-10.15%-52.65%+169,999,900.00%
Expensify, Inc. stock logo
EXFY
Expensify
-3.90%+9.90%+24.02%+94.74%+23.33%
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
-1.19%-3.04%-4.60%0.00%+2.72%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
+0.52%-5.35%-45.97%-60.47%-65.21%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BGIN
Bgin Blockchain
1.00
SellN/AN/A
Expensify, Inc. stock logo
EXFY
Expensify
2.33
Hold$3.0035.14% Upside
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
2.00
HoldN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest NTWK, ZSQR, BGIN, and EXFY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
BGIN
Bgin Blockchain
UpgradeSell (E+)Sell (D-)
8/7/2026
Expensify, Inc. stock logo
EXFY
Expensify
UpgradeMarket OutperformOutperform
8/7/2026
Expensify, Inc. stock logo
EXFY
Expensify
UpgradeMarket PerformOutperform$3.00
7/24/2026
BGIN
Bgin Blockchain
DowngradeSell (D-)Sell (E+)
7/13/2026
BGIN
Bgin Blockchain
UpgradeSell (E)Sell (D-)
7/1/2026
Expensify, Inc. stock logo
EXFY
Expensify
UpgradeSell (E+)Sell (D-)
6/29/2026
BGIN
Bgin Blockchain
Reiterated RatingSell (E)
5/19/2026
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
Reiterated RatingHold (C)
(Data available from 8/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BGIN
Bgin Blockchain
$67.40M2.85N/AN/A$0.48 per share3.54
Expensify, Inc. stock logo
EXFY
Expensify
$142.10M1.23N/AN/A$1.70 per share1.31
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
$66.09M0.75$0.37 per share11.21$3.61 per share1.15
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$1.36M147.10N/AN/A$2.63 per share1.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BGIN
Bgin Blockchain
-$176.86MN/AN/AN/AN/AN/AN/AN/AN/A
Expensify, Inc. stock logo
EXFY
Expensify
-$21.39M-$0.17N/AN/AN/A-11.31%-11.54%-8.34%N/A
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
$2.92M$0.1527.67N/AN/A2.49%4.24%2.76%9/28/2026 (Estimated)
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-$11.92M-$2.52N/AN/AN/A-810.04%-92.29%-73.52%N/A

Latest NTWK, ZSQR, BGIN, and EXFY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2026Q3 2026
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
$0.08$0.11+$0.03$0.11$15.10 million$19.83 million
5/14/2026Q1 2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A-$0.65N/A-$0.65N/A$0.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BGIN
Bgin Blockchain
N/AN/AN/AN/AN/A
Expensify, Inc. stock logo
EXFY
Expensify
N/AN/AN/AN/AN/A
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
N/AN/AN/AN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BGIN
Bgin Blockchain
N/A
1.68
1.47
Expensify, Inc. stock logo
EXFY
Expensify
N/A
3.50
3.50
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
0.01
1.94
1.94
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
0.01
3.25
3.25

Institutional Ownership

CompanyInstitutional Ownership
BGIN
Bgin Blockchain
N/A
Expensify, Inc. stock logo
EXFY
Expensify
68.42%
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
16.02%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
13.88%

Insider Ownership

CompanyInsider Ownership
BGIN
Bgin Blockchain
N/A
Expensify, Inc. stock logo
EXFY
Expensify
11.65%
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
13.54%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
24.25%
CompanyEmployeesShares OutstandingFree FloatOptionable
BGIN
Bgin Blockchain
101113.14 millionN/AN/A
Expensify, Inc. stock logo
EXFY
Expensify
14078.94 million69.74 millionOptionable
NetSol Technologies Inc. stock logo
NTWK
NetSol Technologies
1,46011.88 million10.27 millionOptionable
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
251.43 million38.96 millionNot Optionable

Recent News About These Companies

Z Squared Inc. Provides Capital Structure Update

Media Sentiment Over Time

Bgin Blockchain NASDAQ:BGIN

$1.70 -0.07 (-4.10%)
As of 08/12/2026 03:59 PM Eastern

Through our operating subsidiaries, we are a digital asset technology company based in Singapore, Hong Kong and the U.S. with proprietary cryptocurrency-mining technologies. We were established as a cryptocurrency mining business in 2019. Given our limited financial resources at the time, we decided to focus on selected alternative cryptocurrencies as it was more cost effective. We leveraged our in-house technical expertise to design the software and the chips that could efficiently mine different types of cryptocurrencies that we focused on. This experience has built our understanding of how to approach designing appropriate software to address the Proof-of-Work (“PoW”) algorithms of various cryptocurrencies. Over time, we have scaled our business and presently operate through subsidiaries located in the United States, Hong Kong and Singapore. We primarily generate revenue from selling self-designed mining machines, conducting mining operations, operating mining pools, and providing mining machine hosting services to customers. Sales of mining machines contributed approximately 85.43% and 63.57% of our total revenue for the fiscal years ended December 31, 2023 and 2024, respectively. While our long-term strategic focus has always been on self-mining and generating service revenue from mining farms and mining pools, we recognized early on that other miners valued our proprietary chip design and mining machines. As an early-stage growth company, we recognized the opportunity to fund our growth strategy by exploiting this interest in our mining machines. We design our mining machines to address the needs the miners of all sizes. Different models of our machines cater to a diverse range of size segments: from small-scale models for home miners to industrial-scale machines tailored for mid-to-large mining enterprises. Our focus has always been on delivering cost effective and energy efficient machines. Our subsidiaries design and sell mining machines equipped with our proprietary ASIC chips under different series dedicated to the mining of KAS coins and ALEO coins, and, prior to March 2025, also ALPH coins and RXD coins. For the years ended December 31, 2023 and 2024, mining machine sales was the primary source of our revenue, representing 85.43% and 63.57% of our total revenue in the respective fiscal year. These machines are available for purchase only through our website: iceriver.io. Customers may view and place orders for machines they intend to purchase directly through the website, and have the option to enroll in our miner hosting services, through which we operate and manage mining machines on customers’ behalf in return for service fees. Customers purchasing machines sold by our subsidiaries are primarily based in Hong Kong, the U.S. and Southeast Asia. For the fiscal years ended December 31, 2023 and 2024, we sold an aggregate of 67,998 and 102,849 mining machines, respectively, to customers across the world. As of the date of this prospectus, we host a total of 1,773 machines on behalf of our customers, of which 1,198 are in operation at our mining farm located in York, Nebraska, and 575 are stored in our warehouse in Beatrice, Nebraska. KAS coin mining machines constitute 90.88% of our machine sales for the fiscal year ended December 31, 2024. There is increased competition in this segment due to an increasing number of KAS machines on the market launched by competitors, and we continually work on refining and developing newer, more efficient ASIC chips and mining machines to retain our status as a market leading brand. We strategically targeted developing an expertise in designing and developing ASIC chips for this cryptocurrency as the mining algorithm underlying this coin is similar to the algorithm utilized by Bitcoin. The experience and insights we have gained position us well to leverage our enhanced financial capacity to design, for our own use and for external sales, mining machines that can expand our business into mining larger cryptocurrencies such as Bitcoin if we decide to take this approach. As our subsidiaries produce cryptocurrencies through their mining operations, they exchange cryptocurrencies mined for fiat currency on a regular basis to generate cash flow to fund our subsidiaries’ business operations. We attribute our substantial growth in the cryptocurrency mining business since our inception to our strategic focus on selected alternative cryptocurrency mining. These selected alternative cryptocurrencies are generally considered to have more growth potential with higher risks compared to large-capitalization cryptocurrencies. To mitigate such risks and maximize profit potential, our subsidiaries adopt a flexible approach to mining operations by using their cloud-based mining machine management software to monitor mining results on a daily basis and, on an as-needed basis, adjust the ratio of cryptocurrencies to be mined. We believe that our innovative research and development capabilities are a key competitive strength as this has enabled us to design and deliver mining machines that are robust and come in various sizes to address the needs of various size segments of the mining industry. Users of our machines, including our subsidiaries, have the ability to conduct cryptocurrency mining with greater computing power and power efficiency while retaining the flexibility to select a machine size that suits their specific needs and storage facility specifications. Our subsidiaries fully rely on our self-designed mining machines for their daily cryptocurrency mining operations. To date, through our subsidiaries, we have designed 27 and put into use 14 different models of cryptocurrency mining machines, each specifically adapted and dedicated to mining a specific cryptocurrency. As of the date of this prospectus, our subsidiaries own a total of 72,825 mining machines for operation purposes, of which 10,180 are in operation, and 62,645 are not operated and are stored in mining farms and hosting facilities in the U.S., our warehouses in Hong Kong and Beatrice, Nebraska, or stored by our partner manufacturer in Malaysia. Through our subsidiaries, we currently manage and operate some of our mining machines in the U.S. at mining farms owned by our subsidiaries in Omaha, Nebraska and York, Nebraska. The remaining mining machines are hosted by third-party hosting service providers at two locations in the states of Texas and Ohio. As of the date of this prospectus, other than 324 mining machines located in our warehouse in Hong Kong and 26,584 mining machines stored by our partner manufacturer in Malaysia, all the mining machines owned by our subsidiaries are located in the U.S. We strive to continuously develop and implement technological improvement into our subsidiaries’ mining process. The technological cornerstone of our subsidiaries’ cryptocurrency mining operations is their proprietary cloud-based mining machine management software, which is used at all of the mining farms in which our subsidiaries maintain and operate mining machines, and allows them to make timely and informed decisions as to the use and management of their mining machines. Since September 2023, we have been providing mining pool services, which currently support five mineable cryptocurrencies, through which we generate income by receiving crypto coins as rewards and deducting a percentage of such rewards as pool fees from payouts to pool participants. For the fiscal years ended December 31, 2023 and 2024, the Company’s business operations were heavily dependent upon KAS coins. Our principal executive offices are located in Singapore.

Expensify stock logo

Expensify NASDAQ:EXFY

$2.22 -0.09 (-3.90%)
Closing price 08/12/2026 04:00 PM Eastern
Extended Trading
$2.22 0.00 (0.00%)
As of 07:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Expensify, Inc. provides a cloud-based expense management software platform to individuals and corporations, small and midsized businesses, and enterprises in the United States and internationally. The company's platform enables users to manage corporate cards, pay bills, generate invoices, collect payments, and book travel. It also offers track and submit plans for individuals. The company was founded in 2008 and is based in Portland, Oregon.

NetSol Technologies stock logo

NetSol Technologies NASDAQ:NTWK

$4.15 -0.05 (-1.19%)
As of 08/12/2026 04:00 PM Eastern

NetSol Technologies, Inc. designs, develops, markets, and exports enterprise software solutions to the automobile financing and leasing, banking, and financial services industries worldwide. The company offers NFS Ascent, a suite of financial applications for businesses in the finance and leasing industry. Its NFS Ascent constituent applications include Omni Point of Sale, a web-based application; Contract Management System (CMS), an application for managing and maintaining credit contracts; Wholesale Finance System (WFS), a system for automating and managing the lifecycle of wholesale finance; Dealer Auditor Access System, a web-based solution that could be used in conjunction with WFS or any third-party wholesale finance system; NFS Ascent deployed on The Cloud, a cloud-version of NFS Ascent; and NFS Digital, that includes Self Point of Sale, Mobile Account, Mobile Point of Sale, Mobile Dealer, Mobile Auditor, Mobile Collector, and Mobile Field Investigator. The company also provides Otoz Digital Auto-Retail and mobility orchestration, a white-label SaaS platform; Otoz Ecosystem, an API-based architecture; and Otoz Platform, a white label platform, which includes Dealer/Admin Tool and Customer Portals. In addition, it offers system integration, consulting, and information technology products and services. It serves blue chip organizations, Dow-Jones 30 Industrials, Fortune 500 manufacturers and financial institutions, and vehicle manufacturers. The company was incorporated in 1997 and is headquartered in Encino, California.

Coeptis Therapeutics stock logo

Coeptis Therapeutics NASDAQ:ZSQR

$3.89 +0.02 (+0.52%)
As of 08/12/2026 04:00 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.